Form 4 Tracker
Century Therapeutics, Inc.
IPSC

38 insider filings · Latest: Sep 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 14, 2026Sep 15 10:25 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Sale
2,587$1.93$5.0K509,198(D)

View →

Sep 14, 2026Sep 15 10:25 PMDouglas CarrSVP Finance & Operations
Sale
1,658$1.93$3.2K502,907(D)

View →

Sep 14, 2026Sep 14 7:31 PMRussotti Gregory
Proposed Sale
2,587$1.93$5.0K—

View →

Sep 14, 2026Sep 14 7:29 PMCarr Douglas
Proposed Sale
1,658$1.93$3.2K—

View →

Sep 8, 2026Sep 9 8:35 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Sale
534$2.05$1.1K511,785(D)

View →

Sep 8, 2026Sep 9 8:34 PMDouglas CarrSVP Finance & Operations
Sale
254$2.05$521504,565(D)

View →

Sep 8, 2026Sep 8 7:10 PMRussotti Gregory
Proposed Sale
534$2.05$1.1K—

View →

Aug 3, 2026Aug 5 8:08 PMDouglas CarrSVP Finance & Operations
Sale
275$1.98$544504,819(D)

View →

Jun 12, 2026Jun 15 11:57 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Sale
2,584$2.23$5.8K512,319(D)

View →

Jun 12, 2026Jun 15 11:56 PMDouglas CarrSVP Finance & Operations
Sale
1,654$2.23$3.7K505,094(D)

View →

Jun 12, 2026Jun 12 7:35 PMRussotti Gregory
Proposed Sale
2,584$2.23$5.8K—

View →

Jun 8, 2026Jun 9 8:10 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Sale
524$2.11$1.1K514,903(D)

View →

Jun 8, 2026Jun 9 8:10 PMDouglas CarrSVP Finance & Operations
Sale
249$2.11$526506,748(D)

View →

Jun 8, 2026Jun 8 7:28 PMRussotti Gregory
Proposed Sale
524$2.11$1.1K—

View →

May 4, 2026May 6 9:27 PMDouglas CarrSVP Finance & Operations
Sale
264$2.34$618506,997(D)

View →

Mar 12, 2026Mar 16 8:04 PMDouglas CarrSVP Finance & Operations
Sale
7,043$2.55$18.0K507,261(D)

View →

Mar 12, 2026Mar 16 8:03 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Sale
10,076$2.55$25.7K515,427(D)

View →

Mar 12, 2026Mar 12 8:23 PMRussotti Gregory
Proposed Sale
10,076$2.55$25.7K—

View →

Mar 9, 2026Mar 11 8:11 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Sale
479$2.54$1.2K525,503(D)

View →

Mar 9, 2026Mar 11 8:10 PMDouglas CarrSVP Finance & Operations
Sale
247$2.54$626514,304(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 9, 2026Sep 10 9:48 PMJoseph TruittDirector
Grant/Award
148,000$2.03148,000(D)

View →

Jun 11, 2026Jun 12 9:08 PMAlessandro RivaDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:07 PMDaphne QuimiDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:06 PMMartin Patrick MurphyDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:05 PMHan Myung LeeDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:05 PMKimberly BlackwellDirector
Grant/Award
74,000$2.2474,000(D)

View →

Dec 9, 2025Apr 10 9:07 PMMartin Patrick MurphyDirector
Grant/Award
88,000$0.59288,000(D)

View →

Feb 2, 2026Feb 4 9:22 PMBrent PfeiffenbergerDirector, President and CEO
Grant/Award
945,000$1.84945,000(D)

View →

Feb 2, 2026Feb 4 9:19 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Grant/Award
265,000$1.84265,000(D)

View →

Feb 2, 2026Feb 4 9:15 PMChad CowanChief Scientific Officer
Grant/Award
265,000$1.84265,000(D)

View →

Feb 2, 2026Feb 4 9:12 PMDouglas CarrSVP Finance & Operations
Grant/Award
225,000$1.84225,000(D)

View →